Nintedanib treatment reduces the levels of circulating cancer antigen 125 in patients with progressive pulmonary fibrosis.
Better lung function, expressed as higher forced vital capacity (FVC), is associated with a reduced risk for the onset of heart disease, diabetes, and stroke over a follow-up period of approximately ...
Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...
Italy: A new cross-sectional study published in Respiratory Research has highlighted a significant association between vertebral fractures and impaired lung function in patients with ...
Progressive pulmonary fibrosis (PPF) represents one of the most challenging phenotypes within the interstitial lung disease ...
In a recent study posted to the Preprints with The Lancet SSRN* server, researchers evaluated the impairment of pulmonary function in individuals suffering from post-acute sequelae of coronavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results